MarketPulse
U

$URGN

2 articles found
1 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Urogen Pharma Ltd.

Bladder Cancer Survey Reveals High Recurrence Fear, Procedural Burden Among Patients

BCAN survey of 1,100+ bladder cancer patients shows 80% experience recurrence fear, exceeding 90% in under-50 cohort. UroGen emphasizes need for treatments balancing tumor control with quality of life.
URGNquality of lifebladder cancer
GlobeNewswire Inc.GlobeNewswire Inc.··Bladder Cancer Advocacy Network (Bcan)

Bladder Cancer Patients Face Diagnosis Delays, Support Gaps Despite Treatment Advances

Survey of 1,100+ bladder cancer patients reveals 45% of women misdiagnosed as UTIs, 41% lack mental health support, and financial barriers limit treatment access.
JNJURGNbladder cancerpatient survey